Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
Neuroscience
|
August 12, 2009
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy
S Giatti, M Pesaresi, G Cavaletti, et al.
European Journal of Neurology
|
September 5, 2012
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings
C Briani, M Campagnolo, M Lucchetta, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 10, 2007
Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy
I Roglio, R Bianchi, S Giatti, et al.
Anticancer Research
|
January 30, 2003
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat
G Cavaletti, M G Petruccioli, P Marmiroli, et al.
Journal of Neuroimmunology
|
February 13, 2010
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis
F Piazza, J C DiFrancesco, M L Fusco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2012
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
A A Argyriou, R Velasco, C Briani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 3, 2020
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
B Jordan, A Margulies, F Cardoso, et al.
European Journal of Neurology
|
December 21, 2012
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study
A A Argyriou, C Briani, G Cavaletti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 4, 2017
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier
R Dal Magro, F Ornaghi, I Cambianica, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 12, 2006
Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis
G Cavaletti, P Perseghin, M Dassi, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
Neuroscience
|
August 12, 2009
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy
S Giatti, M Pesaresi, G Cavaletti, et al.
European Journal of Neurology
|
September 5, 2012
Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings
C Briani, M Campagnolo, M Lucchetta, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 10, 2007
Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy
I Roglio, R Bianchi, S Giatti, et al.
Anticancer Research
|
January 30, 2003
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat
G Cavaletti, M G Petruccioli, P Marmiroli, et al.
Journal of Neuroimmunology
|
February 13, 2010
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis
F Piazza, J C DiFrancesco, M L Fusco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2012
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
A A Argyriou, R Velasco, C Briani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 3, 2020
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
B Jordan, A Margulies, F Cardoso, et al.
European Journal of Neurology
|
December 21, 2012
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study
A A Argyriou, C Briani, G Cavaletti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 4, 2017
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier
R Dal Magro, F Ornaghi, I Cambianica, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 12, 2006
Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis
G Cavaletti, P Perseghin, M Dassi, et al.
Page
of 13